本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Psyence Biomedical Ltd

2.47
-0.0250-1.00%
成交量:7,834.00
成交額:1.95萬
市值:282.76萬
市盈率:-0.07
高:2.51
開:2.48
低:2.41
收:2.49
52周最高:74.94
52周最低:1.92
股本:114.71萬
流通股本:97.07萬
量比:0.99
換手率:0.81%
股息:- -
股息率:- -
每股收益(TTM):-34.7817
每股收益(LYR):32.76
淨資產收益率:-74.29%
總資產收益率:-34.44%
市淨率:0.24
市盈率(LYR):0.08

資料載入中...

2024/10/02

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/08/27

SEC問詢函

Form CORRESP - Correspondence
2024/08/20

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC問詢函

Form CORRESP - Correspondence
2024/05/10

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/09

SEC問詢函

Form CORRESP - Correspondence
2024/05/07

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/06

SEC問詢函

Form CORRESP - Correspondence
2024/04/18

SEC問詢函

Form CORRESP - Correspondence
2024/04/18

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/02/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/23

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/01/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/15

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/11/13

SEC問詢函

Form CORRESP - Correspondence